Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | ¥3.98B | ¥2.77B | ¥2.63B | ¥2.80B | ¥3.21B | ¥3.03B | ¥1.51B |
| Research & development | ¥232.7M | ¥216.5M | ¥299.1M | ¥291.3M | ¥379.0M | ¥244.2M | ¥214.6M |
| Operating expenses | ¥3.61B | ¥2.59B | ¥2.64B | ¥2.32B | ¥5.07B | ¥3.52B | ¥1.71B |
| Operating income | ¥370.9M | ¥178.2M | −¥6.7M | ¥478.0M | −¥1.86B | −¥496.2M | −¥194.5M |
| EBITDAderived | ¥384.8M | ¥189.7M | ¥6.8M | ¥501.0M | −¥1.84B | −¥483.2M | −¥187.8M |
| Net income | ¥568.9M | ¥367.5M | ¥167.2M | ¥607.7M | −¥1.57B | −¥663.9M | −¥321.5M |
| Basic EPSper diluted share | CN¥0.16 | CN¥0.10 | CN¥0.04 | CN¥0.15 | -CN¥0.58 | -CN¥0.94 | -CN¥0.38 |
| Diluted EPSper diluted share | CN¥0.15 | CN¥0.10 | CN¥0.04 | CN¥0.15 | -CN¥0.58 | -CN¥0.94 | -CN¥0.38 |